Advancements in mesenchymal stem cell therapy for liver cirrhosis: Unveiling origins, treatment mechanisms, and current research frontiers
Authors:
- 18 August 2023
- journal article
- research article
- Published by Elsevier in Tissue and Cell
- Vol. 84, 102198
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (2002330)
- Foundation for Innovative Research Groups of the National Natural Science Foundation of China (81972673)
This publication has 80 references indexed in Scilit:
- A pilot study of umbilical cord‐derived mesenchymal stem cell transfusion in patients with primary biliary cirrhosisJournal of Gastroenterology and Hepatology, 2013
- Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells Alleviate Liver FibrosisStem Cells and Development, 2012
- Clonal multipotency and effect of long-term in vitro expansion on differentiation potential of human hair follicle derived mesenchymal stem cellsStem Cell Research, 2012
- TGF-β in progression of liver diseaseCell and tissue research, 2011
- Clinical and laboratory evaluation of patients with end-stage liver cell failure injected with bone marrow-derived hepatocyte-like cellsEuropean Journal of Gastroenterology & Hepatology, 2011
- Pathogenesis of Liver FibrosisAnnual Review of Pathology: Mechanisms of Disease, 2011
- Therapeutic Potentials of Mesenchymal Stem Cells Derived from Human Umbilical CordStem Cell Reviews and Reports, 2010
- Hypoxic Preconditioning Results in Increased Motility and Improved Therapeutic Potential of Human Mesenchymal Stem CellsStem Cells, 2008
- Liver cirrhosisThe Lancet, 2008
- Allogeneic marrow stromal cells are immune rejected by MHC class I– and class II–mismatched recipient miceBlood, 2005